Log on / register
Feedback | Support | My details

Email this article to a friend

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

Florian Then Bergh* email, Tania Kümpfel* email, Erina Schumann email, Ulrike Held email, Michaela Schwan email, Mirjana Blazevic email, Axel Wismüller email, Florian Holsboer email, Alexander Yassouridis email, Manfred Uhr email, Frank Weber email, Martin Daumer email, Claudia Trenkwalder email and Dorothee P Auer email

BMC Neurology 2006, 6:19doi:10.1186/1471-2377-6-19

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.